Improved learning and memory in aged mice deficient in amyloid β-degrading neutral endopeptidase

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Walther, Thomas ^a,b   Albrecht, Doris ^a   Becker, Matthias ^c   Schubert, Manja ^a   Kouznetsova, Elena ^d   Wiesner, Bukard ^c   Maul, Björn ^c   Schliebs, Reinhard ^d   Grecksch, Gisela ^e   Furkert, Jens ^c   Sterner Kock, Anja ^f   Schultheiss, Heinz Peter ^a   Becker, Axel ^e   Siems, Wolf Eberhard ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HULL   (United Kingdom)

^c LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

^f FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GALANIN; GALANIN LIKE PEPTIDE; NEUTRAL PROTEINASE;

AGING; AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN SLICE; CONTROLLED STUDY; DEMENTIA; DRUG MECHANISM; ENZYME DEFICIENCY; ENZYME INHIBITION; GENOTYPE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LEARNING; LONG TERM POTENTIATION; MALE; MAZE TEST; MEMORY; MOUSE; NEUROPATHOLOGY; NONHUMAN; PROTEIN DEGRADATION;

MUS;

EID: 84887212630     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004590     Document Type: Article

References (56)

1. Carson JA, Turner AJ (2002) Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J Neurochem 81: 1-8.
2. Tanzi RE, Moir RD, Wagner SL (2004) Clearence of Alzheimer's Abeta peptide: the many roads of perdition. Neuron 43: 605-608.
3. Turner AJ, Fisk L, Nalivaeva NN (2004) Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration. Ann NY Acad Sc 1035: 1-20.
4. Saido TC, Iwata N (2006) Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease. Towards presymptomatic diagnosis, prevention and therapy. Neurosci Res 54: 235-253.
5. El-Amouri SS, Zhu H, Yu J, Marr R, Verma IM, et al. (2008) Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Am J Pathol 172: 1342-54.
6. Howell S, Nalbantoglu J, Crine P (1995) Neutral endopeptidase can hydrolyze beta-amyloid (1-40) but shows no effect on beta-amyloid precursor protein metabolism. Peptides 16: 647-652.
7. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, et al. (2000) Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6: 143-150.
8. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnic Z, et al. (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120: 701-713.
9. Iwata N, Takaki Y, Fukami S, Tsubuki S, Saido TC (2002) Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J Neuros Res 70: 493-500.
10. Kanemitsu H, Tomiyama T, Mori H (2003) Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form. Neurosci Lett 350: 113-116.
11. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, et al. (2001) Metabolic regulation of brain Abeta by neprilysin. Science 292: 1550-1552.
12. Huang SM, Mouri A, Kokubo H, Nakajima R, Suemoto T, et al. (2006) Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function. J Biol Chem 281: 17941-17951.
13. Lu B, Gerard NP, Kolakowski LF jr, Bozza M, Zurakowski D, et al. (1995) Neutral endopeptidase modulation of septic shock. J Exp Med 181: 2271-2275.
14. Lu B, Figini M, Emanueli C, Geppetti P, Grady EF, et al. (1997) The control of microvascular permeability and blood pressure by neutral Endopeptidase. Nat Med 3: 904-907.
15. Dudal S, Figini M, Emanueli C, Geppetti P, Grady EF, et al. (2004) Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Neurobio Aging 25: 861-871.
16. Tucker HM, Simpson J, Kihiko-Ehmann M, Younkin LH, McGillis JP, et al. (2004) Plasmin deficiency does not alter endogenous murine amyloid beta levels in mice. Neurosci Lett 368: 285-289.
17. Dolev I, Michaelson DM (2004) A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc Natl Acad Sci (USA) 101: 13909-139014.
18. Shirotani K, Tsubuki S, Iwata N, Takaki Y, Harigaya W, et al. (2001) Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J Biol Chem 276: 21895-21901.
19. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, et al. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539.
20. Demuro A, Mina E, Kayed R, Milton SC, Parker I, et al. (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280: 17294-17300.
21. Chaputhier G, Venault P (2002) GABA-A receptor complex and memory processes. Curr Top Med Chem 2: 841-851.
22. Kalueff A, Nutt DJ (1996) Role of GABA in memory and anxiety. Depress Anxiety 4: 100-110.
23. Bliss TV, Lomo T (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol (Lond) 232: 331-356.
24. LeDoux JE (1993) Emotional memory systems in the brain. Behav Brain Res 58: 69-79.
25. von Bohlen und Halbach O, Albrecht D (2002) Reciprocal connections of the hippocampal area CA1, the lateral nucleus of the amygdala and cortical areas in a combined horizontal slice preparation. Neurosci Res 44: 91-100.
26. Kaschel T, Schubert M, Albrecht D (2004) Long-term depression in horizontal brain slices of the lateral amygdale. Synapse 53: 141-150.
27. Lanahan A, Lyford G, Stevenson GS, Worley PF, Barnes CA (1997) Selective alteration of long-term potentiation-induced transcriptional response in hippocampus of aged, memory-impaired rats. J Neurosci 17: 2876-2885.
28. Moore CI, Browning MD, Rose GM (1993) Hippocampal plasticity induced by primed burst, but not long-term potentiation, stimulation is impaired in area CA1 of aged Fischer 344 rats. Hippocampus 3: 57-66.
29. Larson J, Lynch G (1988) Role of N-methyl-D-aspartate receptors in the induction of synaptic potentiation by and burst stimulation patterned after the hippocampal theta-rhythm. Brain Res 441: 111-118.
30. Shankar S, Teyle TJ, Robbins N (1998) Aging differentially alters forms of long-term potentiation in rat hippocampal area CA1. J Neurophysiol 79: 334-341.
31. Mohajeri MH, Kuehnle K, Li H, Poirier R, Tracy J, et al. (2004) Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease. FEBS Lett 562: 16-21.
32. Eichenbaum H (1995) Spatial learning. The LTP-memory connection. Nature 378: 131-132.
33. Morris RG, Frey U (1997) Hippocampal synaptic plasticity: role in spatial learning or the automatic recording of attended experience? Philos Trans R Soc Lond B Biol Sci 352: 1489-1503.
34. Zou LB, Mouri A, Iwata N, Saido TC, Wang D, et al. (2005) Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid Beta and impairment of learning and memory. J Pharmacol Exp Ther 317: 334-340.
35. Mouri A, Zou LB, Iwata N, Saido TC, Wang D, et al. (2006) Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory. Behav Brain Res 168: 83-91.
36. Heinrichs M, Meinlschmidt G, Wippich W, Ehlert U, Hellhammer DH (2004) Selective amnesic effects of oxytocin on human memory. Physiol Behav 83: 31-38.
37. Carvajal CC, Vercauteren F, Dumont Y, Michalkiewicz M, Quirion R (2004) Aged Neuropeptide Y transgenic rats are resistant to acute stress but maintain spatial and non-spatial learning. Behav Brain Res 153: 471-480.
38. Hadjiivanova C, Blecheva S, Blecheva I (2003) Cholecystokinin and learning and memory process (Review). Acta Physiol Pharmacol Bulg 27: 83-88.
39. Hupe-Sodmann K, McGregor GP, Bridenbaugh R, Goke R, Goke B, et al. (1995) Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides. Regul Pept 58: 149-156.
40. During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, et al. (2003) Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 9: 1173-1179.
41. Mataro M, Poca MA, Del Mar Matarin M, Catalan R, Sahuquillo J, et al. (2003) CSF galanin and cognition after shunt surgery in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 74: 1272-1277.
42. Brewer A, Echevarria DJ, Lange U, Robinson JK (2005) Assessment of new functional roles for galanin in the CNS. Neuropeptides 39: 323-326.
43. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, et al. (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15: 1203-1218.
44. Sturiale S, Barbara G, Qiu B, Figini M, Geppetti P, et al. (1999) Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci USA 96: 11653-11658.
45. Siems WE, Maul B, Krause W, Gerard C, Hauser KF, et al. (2000) Neutral endopeptidase and alcohol consumption, experiments in neutral endopeptidase-deficient mice. Eur J Pharmacol 397: 327-334.
46. Fischer HS, Zernig G, Hauser KF, Gerard C, Hersh LB, et al. (2002) Neutral endopeptidase knockout induces hyperalgesia in a model of visceral pain, an effect related to bradykinin and nitric oxide. J Mol Neurosi 18: 129-134.
47. Marr RA, Guan H, Rockenstein E, Kindy M, Gage FH, et al. (2004) Neprilysin regulates amyloid Beta peptide levels. J Mol Neurosi 22: 5-11.
48. Braak H, Braak E (1997) Staging of Alzheimer-related cortical destruction. Int Psychogeriat 9 Suppl 1: 257-261.
49. Franklin KBJ, Paxinos D (1997) The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
50. Popov N, Pohle W, Lossner S, Schulzeck S, Schmidt S, et al. (1973) Regional distribution of RNA and protein radioactivity in the rat brain after intraventricular application of labeled precursors. Acta Biol Med Germ 31: 51-362.
51. Njung'e K, Handley SL (1991) Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents. Br J Pharmacol 104: 105-112.
52. Gyertyan I (1995) Analysis of the marble burying response: marbles serve to measure digging rather than evoke burying. Behav Pharmacol 6: 24-31.
53. Martin JR, Bos M, Jenck F, Moreau J, Mutel V, et al. (1998) 5-HT2C receptor agonists pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286: 913-924.
54. Drephal C, Schubert M, Albrecht D (2006) Input-specific long-term potentiation in the rat lateral amygdala of horizontal slices. Neurobiol Learn Mem 85: 272-282.
55. Watanabe Y, Ikegaya Y, Saito H, Abe K (1995) Roles of GABAA, NMDA and muscarinic receptors in induction of long-term potentiation in the medial and lateral amygdala in vitro. Neurosci Res 21: 317-322.
56. Doyere V, Schafe GE, Sigurdsson T, LeDoux JE (2003) Long-term potentiation in freely moving rats reveals asymmetries in thalamic and cortical inputs to the lateral amygdale. Eur J Neurosci 17: 2703-2715.